Related Experiment Video
Updated: Jan 7, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Risk and prognosis of colorectal cancer following bacteraemia with Streptococcus bovis-Streptococcus equinus complex:
Jonas Öberg1,2, Pamela Buchwald3,4, Anton Nilsson5
1Department of Clinical Sciences Lund, Section for Infection Medicine, https://ror.org/012a77v79Lund University, Sweden.
Abstract:
There is a positive association between bacteraemia with Streptococcus bovis-Streptococcus equinus complex (SBSEC) and colorectal cancer (CRC). However, the relationship between the timing of SBSEC bacteraemia and CRC is not well-established. Associations with other gastrointestinal cancers have also been suggested. Using national registries, we retrospectively examined the incidence of CRC and other gastrointestinal cancers after SBSEC-bacteraemia in Sweden 2010-2019, and analysed the timing, characteristics, and prognosis of diagnosed CRC. Individuals with SBSEC-bacteraemia were matched to randomly selected controls from the general population at a 1:10 ratio. Cox-regression determined CRC hazard ratios (HR). In total, 908 individuals with SBSEC-bacteraemia were identified and 9,080 controls, of whom 75/908 (8.3%) and 168/9080 (1.9%) respectively had previously diagnosed CRC (p < 0.01). During follow-up of individuals without previous CRC, CRC was diagnosed in 45/833 (5.4%) individuals with SBSEC and 114/8912 (1.3%) controls (p < 0.01). The HR of CRC diagnosis for SBSEC was 10.3 (95% CI 6.7-15.8) overall and 19.8 (95% CI 11.1-35.3) during the first year of follow-up. In conclusion, there was an increased incidence of CRC, and most were diagnosed within the first year. Neither the tumour location, -stage, or -grade of diagnosed CRC nor the rates of other gastrointestinal cancers differed significantly.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

